Mid Atlantic Bio Angels
VC Fund
New York, United States
Mid Atlantic Bio Angels is a VC fund in New York focused on Biotechnology and Health Care. Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life sciencecompany venture arms wishing to invest alongside the angels.MABA places no geographical restrictions or requirements for presenting companies, as long as meaningful and effective post-investment monitoring of these companies can be achieved.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 31%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mid Atlantic Bio Angels invests in
Stages Mid Atlantic Bio Angels invests in
Countries Mid Atlantic Bio Angels invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 13 (50%)
- Health Care 10 (38%)
- Medical Device 8 (31%)
- Medical 5 (19%)
- Therapeutics 4 (15%)
Stage
- Funding Round 7 (27%)
- Series A 5 (19%)
- Seed 4 (15%)
- Angel 4 (15%)
- Series B 3 (12%)
Country
- United States 15 (58%)
- France 1 (4%)
- Israel 1 (4%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Eric D. Kanter
Member--Steering Committee
|
Member--Steering Committee | Total investments: 0 | Find email | |
John Oates
Member
|
Member | Total investments: 0 | Find email | |
Kenny Nova
Member / Investor
|
Member / Investor | Total investments: 0 | Find email | |
Stephen Goodman
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
Yaniv Sneor
Founder
|
Founder | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BMI OrganBank
|
BMI OrganBank develops innovative medical devices and perfusion technology to enhance organ and tissue preservation for transplantation. The company collaborates with academic institutions to expand the possibilities of organ transplantation and improve patient outcomes. BMI OrganBank focuses on creating solutions that could transform kidneytransplantation and other organ preservation methods, benefiting thousands of patients in need of transplants. | Venture - Series Unknown / Jan 12, 2026 | |
Astrocyte Pharmaceuticals
|
Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M / Series B / Aug 18, 2023 | |
Hilltop BioSciences
|
Hilltop Bio provides regenerative therapies that help injured horses regenerate damaged tissues and assist in restoring them. It utilizes its backgrounds in veterinary therapies to find better ways to help horses heal. It is driven by its mission of producing regenerative therapies that science has proven to be safe, effective, and rapid.Thecompany was founded in 2018 and is headquartered in Mansfield, Massachusetts. | Angel / Mar 30, 2023 | |
|
Hilltop BioSciences
|
Hilltop Bio provides regenerative therapies that help injured horses regenerate damaged tissues and assist in restoring them. It utilizes its backgrounds in veterinary therapies to find better ways to help horses heal. It is driven by its mission of producing regenerative therapies that science has proven to be safe, effective, and rapid.Thecompany was founded in 2018 and is headquartered in Mansfield, Massachusetts. | Seed / Mar 30, 2023 | |
The Shape Sensing Company
|
The Shape Sensing Company provides 3D shape-sensing solutions for the medical, aerospace, and energy sectors. | Angel / Nov 10, 2022 | |
FEMSelect
|
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. | $9M / Series B / Oct 19, 2022 | |
DeepLife
|
DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.DeepLife is a biotech company with a mission to build the next generation of system biology. The company works in a highly collaborative translational manner, to facilitate the transition of discoveries from the laboratory to patients. Thecompany operates through collaboration with academic groups in their respective areas of expertise. | $5.9M / Series A / Oct 18, 2022 | |
New View Surgical
|
New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort™ System, a novel surgical imaging and access system for minimally invasive surgery. The company is led by an experienced team of medical device innovators and commercial experts who have come together to design andcommercialize impactful solutions that meet a variety of unmet market needs. The company’s proprietary VisionPort™ system combines multiple imaging and access devices into just one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical and economic advantages to minimally invasive surgery operating rooms around the world. | $9M / Series B / Nov 02, 2021 | |
Seneca Therapeutics
|
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate.Seneca Therapeutics isheadquartered in Blue Bell, Pennsylvania. | $5M / Venture - Series Unknown / May 04, 2021 | |
|
Astrocyte Pharmaceuticals
|
Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M / Series A / May 03, 2021 | |
| See all 26 investments → | |||
Co-Investors
New York Angels
6 deals together
Keiretsu Forum
5 deals together
Keiretsu Capital
4 deals together
Life Science Angels
3 deals together
AJI Capital
2 deals together
Ariel Southeast Angel Partners
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mid Atlantic Bio Angels invest in?
Mid Atlantic Bio Angels invests primarily in Biotechnology, Health Care and Medical Device startups, most often at Funding Round and Series A stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mid Atlantic Bio Angels?
Public channels for Mid Atlantic Bio Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mid Atlantic Bio Angels?
The team at Mid Atlantic Bio Angels includes Eric D. Kanter (Member--Steering Committee), John Oates (Member) and Kenny Nova (Member / Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
